ID   AGC-78
AC   CVCL_B6D3
DR   Wikidata; Q111732899
RX   Patent=EP0336405B1;
RX   PubMed=1369279;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1812.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50165.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: Human cancer cell line A431.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z044 ! TAW-925
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
RX   Patent=EP0336405B1;
RA   Iwasa S., Kuriyama M., Okazaki K., Toyoda Y.;
RT   "Anti-human cancer protein complexes, their production and use.";
RL   Patent number EP0336405B1, 13-Jan-1993.
//
RX   PubMed=1369279; DOI=10.1007/BF00148811;
RA   Honda S., Ichimori Y., Iwasa S.;
RT   "A human hybrid hybridoma producing a bispecific monoclonal antibody
RT   that can target tumor cells for attack by Pseudomonas aeruginosa
RT   exotoxin A.";
RL   Cytotechnology 4:59-68(1990).
//